ClinicalTrials.govpublic full text
Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
type 2 diabetes mellitus, diabetes mellitus, type ii, nateglinide, pioglitazone, combination drug therapy, treatment, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 836243
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.